APA (7th ed.) Citation

W, Q., Y, F., Z, W., L, D., & Y, L. (2026). Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Drugs, 86(2), 217. https://doi.org/10.1007/s40265-025-02274-x

Chicago Style (17th ed.) Citation

W, Qiao, Feng Y, Wen Z, Dou L, and Li Y. "Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials." Drugs 86, no. 2 (2026): 217. https://doi.org/10.1007/s40265-025-02274-x.

MLA (9th ed.) Citation

W, Qiao, et al. "Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials." Drugs, vol. 86, no. 2, 2026, p. 217, https://doi.org/10.1007/s40265-025-02274-x.